UK-Bristol-BRISTOLCENTRE

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Acute myeloid leukaemia2 trials

Phase

• Phase 32 trials

Status

• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Stichting Hemato-Oncologie voor Volwassenen Nederland2 trials

Running trials

• Recruiting

  Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy

  NCT07075016· Phase 3· Stichting Hemato-Oncologie voor Volwassenen Nederland· Source

  Contact: Dr Priyanka Mehta

• Recruiting

  Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

  NCT06652438· Phase 3· Stichting Hemato-Oncologie voor Volwassenen Nederland· Source

  Contact: P. Mehta

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute myeloid leukaemia2 recruiting